Sotera Health (SHC) Revenue & Revenue Breakdown
Sotera Health Revenue Highlights
Latest Revenue (Y)
$1.10B
Latest Revenue (Q)
$311.31M
Main Segment (Y)
Service
Main Geography (Y)
UNITED STATES
Sotera Health Revenue by Period
Sotera Health Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $1.10B | 4.88% |
| 2023-12-31 | $1.05B | 4.54% |
| 2022-12-31 | $1.00B | 7.75% |
| 2021-12-31 | $931.48M | 13.85% |
| 2020-12-31 | $818.16M | 5.12% |
| 2019-12-31 | $778.33M | 4.31% |
| 2018-12-31 | $746.15M | - |
Sotera Health generated $1.10B in revenue during NA 2024, up 4.88% compared to the previous quarter, and up 141.39% compared to the same period a year ago.
Sotera Health Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $311.31M | 5.77% |
| 2025-06-30 | $294.34M | 15.64% |
| 2025-03-31 | $254.52M | -12.29% |
| 2024-12-31 | $290.20M | 1.66% |
| 2024-09-30 | $285.47M | 3.21% |
| 2024-06-30 | $276.59M | 11.45% |
| 2024-03-31 | $248.18M | -20.00% |
| 2023-12-31 | $310.24M | 17.88% |
| 2023-09-30 | $263.18M | 3.09% |
| 2023-06-30 | $255.28M | 15.73% |
| 2023-03-31 | $220.59M | -12.32% |
| 2022-12-31 | $251.59M | 1.16% |
| 2022-09-30 | $248.70M | -6.73% |
| 2022-06-30 | $266.64M | 12.62% |
| 2022-03-31 | $236.75M | -1.86% |
| 2021-12-31 | $241.25M | 6.67% |
| 2021-09-30 | $226.16M | -10.22% |
| 2021-06-30 | $251.92M | 18.75% |
| 2021-03-31 | $212.15M | -2.17% |
| 2020-12-31 | $216.84M | 8.41% |
| 2020-09-30 | $200.03M | -6.13% |
| 2020-06-30 | $213.09M | 13.22% |
| 2020-03-31 | $188.20M | -2.73% |
| 2019-12-31 | $193.49M | -0.94% |
| 2019-09-30 | $195.32M | 0.29% |
| 2019-06-30 | $194.76M | - |
| 2019-03-31 | $194.76M | - |
Sotera Health generated $311.31M in revenue during Q3 2025, up 5.77% compared to the previous quarter, and up 112.55% compared to the same period a year ago.
Sotera Health Revenue Breakdown
Sotera Health Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|
| Service | $941.82M | $905.60M | $864.83M | $805.50M |
| Product | $158.62M | $143.69M | $138.86M | $125.98M |
Sotera Health's latest annual revenue breakdown by segment (product or service), as of Dec 24: Service (85.59%), and Product (14.41%).
Quarterly Revenue by Product
| Product/Service | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product | $55.78M | $37.10M | $30.58M | $51.41M | $46.68M | $38.84M | $21.70M | $72.32M | $36.06M | $29.23M | $6.08M | $31.21M | $32.00M | $45.11M | $30.54M | $33.66M | $25.66M | $43.21M | $23.45M |
| Service | $255.53M | $257.24M | $223.94M | $238.79M | $238.79M | $237.76M | $226.48M | $237.92M | $227.12M | $226.05M | $214.51M | $220.38M | $216.70M | $221.53M | $206.22M | $207.59M | $200.50M | $208.71M | $188.70M |
Sotera Health's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Service (82.08%), and Product (17.92%).
Sotera Health Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|
| Europe | $196.01M | $187.54M | $166.03M | $161.81M |
| Other Geographical Areas | $78.86M | $78.73M | $69.90M | $63.89M |
| UNITED STATES | $616.68M | $590.97M | $579.02M | $527.91M |
| CANADA | $208.89M | $192.05M | $188.74M | $177.88M |
Sotera Health's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (56.04%), CANADA (18.98%), Europe (17.81%), and Other Geographical Areas (7.17%).
Sotera Health Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| OSCR | Oscar Health | $9.18B | $2.99B |
| OPCH | Option Care Health | $5.00B | $1.44B |
| BLCO | Bausch + Lomb | $4.77B | $1.28B |
| TFX | Teleflex | $3.05B | $913.02M |
| ALKS | Alkermes | $1.56B | $394.19M |
| MMSI | Merit Medical Systems | $1.30B | $384.16M |
| SHC | Sotera Health | $1.10B | $311.31M |
| TMDX | TransMedics Group | $441.54M | $143.82M |
| GKOS | Glaukos | $383.48M | $133.54M |
| ACLX | Arcellx | $107.94M | $7.55M |
| PTGX | Protagonist Therapeutics | - | - |